Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients

Getnet Yimer, Getachew Aderaye, Wondwossen Amogne et al. · 2008

Read Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients by Getnet Yimer, Getachew Aderaye, Wondwossen Amogne et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001809.txt.

Description

Getnet Yimer, Getachew Aderaye, Wondwossen Amogne, and their co-authors studied liver damage from tuberculosis drugs in Ethiopia in a 2008 PLOS ONE research article. Anti-tuberculosis therapy can injure the liver, a side effect called hepatotoxicity. The team set out to assess and compare its prevalence, severity, and prognosis in TB patients with and without HIV.

They enrolled 103 HIV-positive and 94 HIV-negative TB patients and evaluated all of them during treatment. The full text gives the liver injury rates and outcomes in each group. Co-infected patients take many drugs at once, so knowing whether HIV raises liver risk helps clinics schedule monitoring where it counts most.

Catalog record

CREATORGetnet Yimer, Getachew Aderaye, Wondwossen Amogne et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001809

Browse the full library · About the Tower of Babel